Comparison of an Intraoperative Application of a Haemostatic Agent (PerClot<sup>®</sup>) with Conventional Haemostatic Procedure after Thyroid Resection — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Comparison of an Intraoperative Application of a Haemostatic Agent (PerClot<sup>®</sup>) with Conventional Haemostatic Procedure after Thyroid Resection
Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
,
Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
,
Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
,
Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
,
Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
,
Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
1 Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
2 Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
3 Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
4 Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
5 Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
6 Allgemein und Visceralchirurgie Krankenhaus Agatharied, Hausham, Germany
Background: Postoperative hemorrhage remains an uncommon but potentially life-threatening complication of thyroid surgery. The aim of this case-controlled study was to compare the effectiveness of PerClot ® hemostatic agent with hemostasis by conventional technique (HCT) in thyroid surgery. Methods: The thyroid resection was performed from November 2009 to February 2010. Exclusion criteria were applied. There were 30 patients in the HCT group and 30 patients in the PerClot ® group. The outcome parameters were postoperative bleeding, the drainage volume 24 hours postoperatively and adverse events according to PerClot ® . Results: There was no post-operative hemorrhage in both groups. We found no significant difference between the control andPerClot ® group with regard to total drainage volume after 24 h (51 ml ± 36.9 control group/53 ml ± 39.5 PerClot ® group (p = 0.79)). There were no adverse events in the PerClot ® group. Conclusions: Routine use of PerClot ® hemostatic agent has no advantage over conventional hemostasis technique (HCT) in thyroid surgery. In addition, PerClot ® is safe and well tolerated.
Musholt, T.J., Clerici, T., Dralle, H., Frilling, A., Goretzki, P.E. and Hermann, M.M. (2011) German Association of Endocrine Surgeons Practice Guidelines for the Surgical Treatment of Benign Thyroid Disease. Langenbeck’s Archives of Surgery, 396, 639-649. http://dx.doi.org/10.1007/s00423-011-0774-y
Dralle, H. (2009) Chirurgische Arbeitsgemeinschaft Endokrinologie der Deutschen Gesellschaft für Allgemeinund Viszeralchirurgie und für die Deutsche Gesellschaft für Chirurgie. Identification of the Recurrent Laryngeal Nerve and Parathyroids in Thyroid Surgery. Chirurgie, 80, 352-363. http://dx.doi.org/10.1007/s00104-008-1646-z
Roher, H.D., Goretzki, P.E., Hellmann, P. and Witte, J. (1999) Complications in Thyroid Surgery. Incidence and Therapy. Chirurgie, 70, 999-1010. http://dx.doi.org/10.1007/s001040050757
Thompson, N.W., Olsen, W.R. and Hoffman, G.L. (1973) The Continuing Development of the Technique of Thyroidectomy. Surgery, 73, 913-927.
Harding, J., Sebag, F., Sierra, M., Palazzo, F.F. and Henry, J.F. (2006) Thyroid Surgery: Postoperative Hematoma-Prevention and Treatment. Langenbeck’s Archives of Surgery, 391, 169-173. http://dx.doi.org/10.1007/s00423-006-0028-6
Testini, M., Marzaioli, R., Lissidini, G., Lippolis, A., Logoluso, F., Gurrado, A., et al. (2009) The Effectiveness of FloSeal Matrix Hemostatic Agent in Thyroid Surgery: A Prospective, Randomized, Control Study. Langenbeck’s Archives of Surgery, 394, 837-842. http://dx.doi.org/10.1007/s00423-009-0497-5
Guler, M., Maralcan, G., Kul, S., Baskonus, I. and Yilmaz, M. (2011) The Efficacy of Ankaferd Blood Stopper for the Management of Bleeding Following Total Thyroidectomy. Journal of Investigative Surgery, 24, 205-210. http://dx.doi.org/10.3109/08941939.2011.586092
Puzziello, A., Rosato, L., Innaro, N., Orlando, G., Avenia, N., Perigli, G., et al. (2014) Hypocalcemia Following Thyroid Surgery: Incidence and Risk Factors. A Longitudinal Multicenter Study Comprising 2631 Patients. Endocrine, 47, 537-542. http://dx.doi.org/10.1007/s12020-014-0209-y
Promberger, R., Ott, J., Kober, F., Koppitsch, C., Seemann, R., Freissmuth, M., et al. (2012) Risk Factors for Postoperative Bleeding after Thyroid Surgery. British Journal of Surgery, 99, 373-379. http://dx.doi.org/10.1002/bjs.7824
Campbell, M.J., McCoy, K.L., Shen, W.T., Carty, S.E., Lubitz, C.C., Moalem, J., et al. (2013) A Multi-Institutional International Study of Risk Factors for Hematoma after Thyroidectomy. Surgery, 154, 1283-1291. http://dx.doi.org/10.1016/j.surg.2013.06.032
Browder, I.W. and Litwin, M.S. (1986) Use of Absorbable Collagen for Hemostasis in General Surgical Patients. The American Surgeon, 52, 492-494.
Haas, S. (2006) The Use of a Surgical Patch Coated with Human Coagulation Factors in Surgical Routine: A Multicenter Postauthorization Surveillance. Clinical and Applied Thrombosis/Hemostasis, 12, 445-450. http://dx.doi.org/10.1177/1076029606293420
Tae, W.K., Choi, S.Y., Jang, M.S., Lee, G.G., Nam, M.E., Son, Y.I., et al. (2012) Efficacy of Fibrin Sealant for Drainage Reduction in Total Thyroidectomy with Bilateral Central Neck Dissection. Otolaryngology—Head and Neck Surgery, 147, 654-660. http://dx.doi.org/10.1177/0194599812449315
Amit, M., Binenbaum, Y., Cohen, J.T. and Gil, Z. (2013) Effectiveness of an Oxidized Cellulose Patch Hemostatic Agent in Thyroid Surgery: A Prospective, Randomized, Controlled Study. Journal of the American College of Surgeons, 217, 221-225. http://dx.doi.org/10.1016/j.jamcollsurg.2013.03.022
Dionigi, G., Boni, L., Rovera, F. and Dionigi, R. (2007) Dissection and Hemostasis with Hydroxilated Polyvinyl Acetal Tampons in Open Thyroid Surgery. Annals of Surgical Innovation and Research, 1, 3. http://dx.doi.org/10.1186/1750-1164-1-3
Wang, Y., Xu, M., Dong, H., Liu, Y., Zhao, P., Niu, W., et al. (2012) Effects of PerClot® on the Healing of Full-Thickness Skin Wounds in Rats. Acta Histochemica, 114, 311-317. http://dx.doi.org/10.1016/j.acthis.2011.06.012
Janczak, D., Ruciński, A., Rucińska, Z., Janczak, D., Dorobisz, K. and Chabowski, M. (2013) Modern Topical Hemostatic Agents—A Breakthrough in Vascular Surgery. Polimery w Medycynie, 43, 221-225.
Bergenfelz, A., Jansson, S., Kristoffersson, A., Martensson, H., Reihnér, E., Wallin, G., et al. (2008) Complications to Thyroid Surgery: Results as Reported in a Database from a Multicenter Audit Comprising 3,660 Patients. Langenbeck’s Archives of Surgery, 393, 667-673. http://dx.doi.org/10.1007/s00423-008-0366-7
Cakabay, B., Sevinc, M.M., Gomceli, I., Yenidogan, E., Ulkü, A. and Koc, S. (2009) LigaSure versus Clamp-and-Tie in Thyroidectomy: A Single-Center Experience. Advances in Therapy, 26, 1035-1041. http://dx.doi.org/10.1007/s12325-009-0078-6
Gentileschi, P., D’Ugo, S., Iaculli, E. and Gaspari, A.L. (2011) Harmonic Focus TM versus “Knot Tying” during Total Thyroidectomy: A Randomized Trial. Updates in Surgery, 63, 277-281. http://dx.doi.org/10.1007/s13304-011-0099-y
Garas, G., Okabaysashi, K., Ashrafian, H., Shetty, K., Palazzo, F., Tolley, N.S., et al. (2013) Which Hemostatic Device in Thyroid Surgery? A Network Meta-Analysis of Surgical Technologies. Thyroid, 23, 1138-1150. http://dx.doi.org/10.1089/thy.2012.0588
Wright, J.D., Ananth, C.V., Lewin, S.N., Burke, W.M., Siddiq, Z., Neugut, A.I., et al. (2014) Patterns of Use of Hemostatic Agents in Patients Undergoing Major Surgery. Journal of Surgical Research, 186, 458-466. http://dx.doi.org/10.1016/j.jss.2013.07.042
Rickenbacher, A., Breitenstein, S., Lesurtel, M. and Frilling, A. (2009) Efficacy of TachoSil a Fibrin-Based Haemostat in Different Fields of Surgery—A Systematic Review. Expert Opinion on Biological Therapy, 9, 897-907. http://dx.doi.org/10.1517/14712590903029172
Maisano, F., Kjaergard, H.K., Bauernschmitt, R., Pavie, A., Rábago, G., Laskar, M., et al. (2009) TachoSil Surgical Patch versus Conventional Haemostatic Fleece Material for Control of Bleeding in Cardiovascular Surgery: A Randomized Controlled Trial. European Journal of Cardio-Thoracic Surgery, 36, 708-714. http://dx.doi.org/10.1016/j.ejcts.2009.04.057
Ujam, A., Awad, Z., Wong, G., Tatla, T. and Farrell, R. (2012) Safety Trial of Floseal® Haemostatic Agent in Head and Neck Surgery. Annals of the Royal College of Surgeons of England, 94, 336-339. http://dx.doi.org/10.1308/003588412X13171221590971
Tonante, A., Lo Schiavo, M.G., Bonanno, L., D’Alia, C., Taranto, F., Gagliano, E., et al. (2006) Haemorrhagic Complications in Thyroid Surgery. Control of Bleeding from Retroneural Vessels Using Collagen and Thrombin Gelatine Granules. Chirurgia Italiana, 58, 61-68.
Spencer, H.T., Hsu, J.T., Mc Donald, D.R. and Karlin, L.I. (2012) Intraoperative Anaphylaxis to Gelatin in Topical Hemostatic Agents during Anterior Spinal Fusion: A Case Report. The Spine Journal, 12, e1-e6. http://dx.doi.org/10.1016/j.spinee.2012.08.425
Tublin, M.E., Alexander, J.M. and Ogilvie, J.B. (2010) Appearance of Absorbable Gelatin Compressed Sponge on Early Post-Thyroidectomy Neck Sonography: A Mimic of Locally Recurrent or Residual Thyroid Carcinoma. Journal of Ultrasound in Medicine, 29, 117-120.
Murat, F.J.L., Ereth, M.H., Dong, Y., Piedra, M.P. and Gettman, M.T. (2004) Evaluation of Microporous Polysaccharide Hemospheres as a Novel Hemostatic Agent in Open Partial Nephrectomy: Favorable Experimental Results in the Porcine Model. The Journal of Urology, 172, 1119-1122. http://dx.doi.org/10.1097/01.ju.0000136001.99920.97
Anegg, U., Rychlik, R. and Smolle-Juttner, F. (2008) Do the Benefits of Shorter Hospital Stay Associated with the Use of Fleece-Bound Sealing Outweigh the Cost of the Materials? Interactive CardioVascular and Thoracic Surgery, 7, 292-296. http://dx.doi.org/10.1510/icvts.2007.162677